Genetic and Epigenetic Interplay Within a COLGALT2 Enhancer Associated With Osteoarthritis
Open Access
- 24 March 2021
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatology
- Vol. 73 (10) , 1856-1865
Abstract
Objective: The osteoarthritis (OA)–associated single‐nucleotide polymorphism (SNP) rs11583641 is located in COLGALT2, encoding a posttranslational modifier of collagen. In cartilage, the SNP genotype correlates with DNA methylation in a putative enhancer. This study was undertaken to characterize the mechanistic relationship between rs11583641, the putative enhancer, and COLGALT2 expression using cartilage samples from human patients and a chondrocyte cell model.Methods: Nucleic acids were extracted from articular cartilage samples obtained from patients with OA (n = 137). Samples were genotyped, and DNA methylation was quantified at 12 CpGs using pyrosequencing. The putative enhancer was deleted in Tc28a2 chondrocytes using clustered regularly interspaced short palindromic repeat/Cas9, and the impact on nearby gene expression was determined using real‐time quantitative polymerase chain reaction. Targeted modulation of the epigenome using catalytically dead Cas9 (dCas9) constructs fused to DNA methyltransferase 3a or ten–eleven translocase 1 allowed for the investigation of a causal relationship between DNA methylation and enhancer activity.Results: The genotype at rs11583641 correlated with DNA methylation at 3 CpGs, and the presence of the OA risk allele, C, corresponded to reduced levels of methylation. Deletion of the enhancer resulted in a 2.7‐fold reduction in COLGALT2 expression. Targeted methylation and demethylation of the CpGs had antagonistic effects on COLGALT2 expression. An allelic imbalance in the expression of COLGALT2 was identified in the cartilage from patients with OA, with relative overexpression of the OA risk allele. Allelic expression ratios correlated with DNA methylation at 4 CpGs.Conclusion: COLGALT2 is a target of OA genetic risk at this locus. The genotype at rs11583641 impacts DNA methylation in a gene enhancer, which, in turn, modulates COLGALT2 expression. COLGALT2 encodes an enzyme that initiates posttranslational glycosylation of collagens and is therefore a compelling OA susceptibility target.Keywords
Funding Information
- Versus Arthritis (20771)
- Seventh Framework Programme (305815)
This publication has 41 references indexed in Scilit:
- A meta-analysis of genome-wide association studies identifies novel variants associated with osteoarthritis of the hipAnnals of the Rheumatic Diseases, 2014
- Severe osteoarthritis of the hand associates with common variants within the ALDH1A2 gene and with rare variants at 1p31Nature Genetics, 2014
- Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association studyThe Lancet, 2012
- Genome-wide association and functional studies identify theDOT1Lgene to be involved in cartilage thickness and hip osteoarthritisProceedings of the National Academy of Sciences, 2012
- A genome-wide association study in 19 633 Japanese subjects identified LHX3-QSOX2 and IGF1 as adult height lociHuman Molecular Genetics, 2010
- Core Glycosylation of Collagen Is Initiated by Two β(1-O)GalactosyltransferasesMolecular and Cellular Biology, 2009
- An SNP in the 5′-UTR of GDF5 is associated with osteoarthritis susceptibility in Europeans and with in vivo differences in allelic expression in articular cartilageHuman Molecular Genetics, 2007
- Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfectaNature Genetics, 2007
- Phenotypic and molecular characterization of Bruck syndrome (osteogenesis imperfecta with contractures of the large joints) caused by a recessive mutation in PLOD2American Journal of Medical Genetics Part A, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001